Tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia
- 31 May 2005
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 52 (5) , S86-S89
- https://doi.org/10.1016/j.jaad.2004.11.018
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Rapid Development of Massive Tendon Xanthomas following Highly Active Antiretroviral TherapyAnnals of Internal Medicine, 2002
- Xanthelasma Palpebrarum: A Review and Current Management PrinciplesPlastic and Reconstructive Surgery, 2002
- XANTHOMAS AND HYPERLIPIDEMIA IN A HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILD RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPYThe Pediatric Infectious Disease Journal, 2002
- Cutaneous manifestations of antiretroviral therapyJournal of the American Academy of Dermatology, 2002
- Hyperlipidemia Associated with the Use of Protease InhibitorsClinical Infectious Diseases, 2000
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Treatment of xanthelasma by excision with secondary intention healingClinical and Experimental Dermatology, 1996
- Ultrapulse CO2 laser ablation of xanthelasmaJournal of the American Academy of Dermatology, 1996
- Dermal, subcutaneous, and tendon xanthomas: Diagnostic markers for specific lipoprotein disordersJournal of the American Academy of Dermatology, 1988
- Xanthomas and hyperlipidemiasJournal of the American Academy of Dermatology, 1985